Mobile

Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-004397-27

Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral contraceptives (OC) to alleviate complaints of reduced libido in women with acquired female sexual dysfunction (FSD) associated with OC-use

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To investigate the effects of 100 mg DHEA per day in women on continuous treatment with a monophasic combined oral contraceptive (COC) who suffer from an acquired OC-associated HSDD as a perceived adverse drug reaction to their OC use. The primary objective will consist of the combined sexual arousal and desire domains of the Female Sexual Function Index (FSFI) self-report questionnaire

Critère d'inclusion

  • Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral contraceptives (OC) to alleviate complaints of reduced libido in women with acquired female sexual disorder (FSD) associated with OC-use

Liens